Yıl: 2021 Cilt: 36 Sayı: 2 Sayfa Aralığı: 308 - 310 Metin Dili: İngilizce DOI: 10.46497/ArchRheumatol.2021.8200 İndeks Tarihi: 29-09-2021

Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis

Öz:
-
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
  • 1. Del Papa N, Onida F, Zaccara E, Saporiti G, Maglione W, Tagliaferri E, et al. Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis. Bone Marrow Transplant 2017;52:53-8.
  • 2. Cipriani P, Ruscitti P, Giacomelli R. Stem cell therapies for systemic sclerosis. Br J Haematol 2015;168:328-37.
  • 3. Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 2017;76:1327-39.
  • 4. Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, et al. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma. N Engl J Med 2018;378:35-47.
  • 5. Del Papa N, Pignataro F, Zaccara E, Maglione W, Minniti A. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis. Front Immunol 2018;9:2390.
  • 6. Nannini C, West CP, Erwin PJ, Matteson EL. Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies. Arthritis Res Ther 2008;10:R124.
  • 7. van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 2014;311:2490-8.
  • 8. Tyndall A. Stem cells: HSCT for systemic sclerosis- -swallows and summers. Nat Rev Rheumatol 2011;7:624-6.
  • 9. Puyade M, Maltez N, Lansiaux P, Pugnet G, Roblot P, Colmegna I, et al. Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant-a systematic review. Rheumatology (Oxford) 2020;59:779-89.
APA Kim N, KIM J, Choi W, Kim K, Lee K, Kim H (2021). Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis. , 308 - 310. 10.46497/ArchRheumatol.2021.8200
Chicago Kim Namho,KIM JONG SUN,Choi Wonho,Kim Kyoung Ha,Lee Kyung-Ann,Kim Hyun-Sook Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis. (2021): 308 - 310. 10.46497/ArchRheumatol.2021.8200
MLA Kim Namho,KIM JONG SUN,Choi Wonho,Kim Kyoung Ha,Lee Kyung-Ann,Kim Hyun-Sook Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis. , 2021, ss.308 - 310. 10.46497/ArchRheumatol.2021.8200
AMA Kim N,KIM J,Choi W,Kim K,Lee K,Kim H Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis. . 2021; 308 - 310. 10.46497/ArchRheumatol.2021.8200
Vancouver Kim N,KIM J,Choi W,Kim K,Lee K,Kim H Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis. . 2021; 308 - 310. 10.46497/ArchRheumatol.2021.8200
IEEE Kim N,KIM J,Choi W,Kim K,Lee K,Kim H "Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis." , ss.308 - 310, 2021. 10.46497/ArchRheumatol.2021.8200
ISNAD Kim, Namho vd. "Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis". (2021), 308-310. https://doi.org/10.46497/ArchRheumatol.2021.8200
APA Kim N, KIM J, Choi W, Kim K, Lee K, Kim H (2021). Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis. Archives of Rheumatology, 36(2), 308 - 310. 10.46497/ArchRheumatol.2021.8200
Chicago Kim Namho,KIM JONG SUN,Choi Wonho,Kim Kyoung Ha,Lee Kyung-Ann,Kim Hyun-Sook Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis. Archives of Rheumatology 36, no.2 (2021): 308 - 310. 10.46497/ArchRheumatol.2021.8200
MLA Kim Namho,KIM JONG SUN,Choi Wonho,Kim Kyoung Ha,Lee Kyung-Ann,Kim Hyun-Sook Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis. Archives of Rheumatology, vol.36, no.2, 2021, ss.308 - 310. 10.46497/ArchRheumatol.2021.8200
AMA Kim N,KIM J,Choi W,Kim K,Lee K,Kim H Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis. Archives of Rheumatology. 2021; 36(2): 308 - 310. 10.46497/ArchRheumatol.2021.8200
Vancouver Kim N,KIM J,Choi W,Kim K,Lee K,Kim H Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis. Archives of Rheumatology. 2021; 36(2): 308 - 310. 10.46497/ArchRheumatol.2021.8200
IEEE Kim N,KIM J,Choi W,Kim K,Lee K,Kim H "Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis." Archives of Rheumatology, 36, ss.308 - 310, 2021. 10.46497/ArchRheumatol.2021.8200
ISNAD Kim, Namho vd. "Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis". Archives of Rheumatology 36/2 (2021), 308-310. https://doi.org/10.46497/ArchRheumatol.2021.8200